Kinetensin
Need Assistance?
  • US & Canada:
    +
  • UK: +

Kinetensin

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Kinetensin (human) is an endogenous neurotensin-like peptide originally isolated from pepsin-treated human plasma. It increases vascular permeability and releases histamine from rat mast cells. It induces histamine release from rat peritoneal mast cells with ED50 value of 10 mM in vitro.

Category
Peptide Inhibitors
Catalog number
BAT-010514
CAS number
103131-69-7
Molecular Formula
C56H85N17O11
Molecular Weight
1172.38
Kinetensin
IUPAC Name
(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid
Synonyms
Kinetensin (human); Neurotensin-related peptide; H-Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu-OH; L-isoleucyl-L-alanyl-L-arginyl-L-arginyl-L-histidyl-L-prolyl-L-tyrosyl-L-phenylalanyl-L-leucine
Appearance
White Lyophilized Powder
Purity
≥95%
Density
1.4±0.1 g/cm3
Sequence
IARRHPYFL
Storage
Store in a cool and dry place and at 2-8°C for short term (days to weeks) or store at -20°C for long term (months to years)
Solubility
Soluble in TFA, Water
InChI
InChI=1S/C56H85N17O11/c1-6-32(4)45(57)52(81)66-33(5)46(75)67-38(15-10-22-63-55(58)59)47(76)68-39(16-11-23-64-56(60)61)48(77)71-42(28-36-29-62-30-65-36)53(82)73-24-12-17-44(73)51(80)70-41(27-35-18-20-37(74)21-19-35)49(78)69-40(26-34-13-8-7-9-14-34)50(79)72-43(54(83)84)25-31(2)3/h7-9,13-14,18-21,29-33,38-45,74H,6,10-12,15-17,22-28,57H2,1-5H3,(H,62,65)(H,66,81)(H,67,75)(H,68,76)(H,69,78)(H,70,80)(H,71,77)(H,72,79)(H,83,84)(H4,58,59,63)(H4,60,61,64)/t32-,33-,38-,39-,40-,41-,42-,43-,44-,45-/m0/s1
InChI Key
PANUJGMSOSQAAY-IHXGQVBNSA-N
Canonical SMILES
CCC(C)C(C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC(C)C)C(=O)O)N
1.Stimulation of white adipose tissue lipolysis by xenin, a neurotensin-related peptide.
Bhavya S;Lew PS;Mizuno TM Biochem Biophys Res Commun. 2018 Apr 15;498(4):842-848. doi: 10.1016/j.bbrc.2018.03.067. Epub 2018 Mar 13.
Xenin is a gastrointestinal hormone that belongs to the neurotensin family. Central administration of xenin to obese mice reduces food intake and body weight gain and causes alterations in the expression of lipid metabolism-related genes and proteins in white adipose tissue (WAT). However, it has not been tested whether or not xenin directly acts on adipose tissue and alters lipid metabolism. The present study was performed to address this possibility by examining the effect of xenin treatment on the levels of glycerol and free fatty acids (FFA) and expression levels of lipolysis marker proteins ex vivo in cultured mouse WAT. Xenin treatment significantly increased concentrations of glycerol and FFA in culture media and increased phosphorylation of hormone sensitive lipase (HSL) in ex vivo cultured WAT. These findings support the hypothesis that xenin directly acts on adipose tissues and stimulates lipolysis. Thus, enhancement of xenin action and its downstream signaling may offer a novel and effective therapy for obese patients by reducing the amount of stored fat in adipose tissue.
2.Effects of neurotensin-related peptides on the motility of the guinea pig oesophagus.
Katsoulis S;Conlon JM Eur J Pharmacol. 1988 Aug 2;152(3):363-6.
Neurotensin, neuromedin N and xenopsin induced a monophasic and concentration-dependent contraction of the intact guinea pig oesophagus but kinetensin was without effect. The responses were completely abolished by tetrodotoxin and atropine but were unaffected by hexamethonium. The maximum response induced by neurotensin was reduced (20-30%) by somatostatin and by dynorphin-(1-13) in a naloxone-reversible manner. Neurotensin did not contract the isolated muscularis mucosae. The effects of neurotensin-related peptides on the motility of the oesophagus are mediated exclusively through the release of acetylcholine.
3.Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons.
Zhang S;Hyrc K;Wang S;Wice BM Am J Physiol Gastrointest Liver Physiol. 2012 Dec 15;303(12):G1347-55. doi: 10.1152/ajpgi.00116.2012. Epub 2012 Oct 18.
Xenin-25 (Xen) is a 25 amino acid neurotensin-related peptide reportedly produced with glucose-dependent insulinotropic polypeptide (GIP) by a subset of K cells in the proximal gut. We previously showed exogenously administered Xen, with GIP but not alone, increases insulin secretion in humans and mice. In mice, this effect is indirectly mediated via a central nervous system-independent cholinergic relay in the periphery. Xen also delays gastric emptying, reduces food intake, induces gall bladder contractions, and increases gut motility and secretion from the exocrine pancreas, suggesting that some effects of Xen could be mediated by myenteric neurons (MENs). To determine whether Xen activates these neurons, MENs were isolated from guinea pig proximal small intestines. Cells expressed neuronal markers and exhibited typical neuron-like morphology with extensive outgrowths emanating from cell bodies. Cytosolic free Ca(2+) levels ([Ca(2+)](i)) were measured using Fura-2. ATP/UTP, KCl, and forskolin increased [Ca(2+)](i) in 99.6%, 92%, and 23% of the MENs imaged, respectively, indicating that they are functional and activated by nucleotide receptor signaling, direct depolarization, and cAMP.
Online Inquiry
Verification code
Inquiry Basket